Revised SPC: Solu-Medrone (methylprednisolone) Powder for Injection – all strengths

Updated to include information on hypertrophic cardiomyopathy, which may develop after administration of methylprednisolone to prematurely born infants. Appropriate diagnostic evaluation and monitoring of cardiac function and structure should be performed.

Source:

electronic Medicines compendium